Chief Legal Officer, Secretary · Cytek Biosciences, Inc. · Cytek Biosciences, Inc. — Employee Stock Option (right to buy)
Side
A
Value
—
Shares
127.1K
Price
—
Executed
Aug 10, 2026
Disclosed
Aug 12, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Aug 10 executedAug 12, 2026 disclosed
CTKB · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Cytek Biosciences, Inc. — Employee Stock Option (right to buy)
Ticker
CTKB
Shares
127.1K
Price per share
$0
Execution date (reported)
Aug 10, 2026
Owned after transaction
127.1K shares
Days from execution to publication
2
What this establishes
Feuchtwang Ilan filed this Form 4 reporting a grant or award of CTKB on Aug 10, 2026. It became public on Aug 12, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Chief Legal Officer, Secretary
Feuchtwang Ilancik:0002141966
Issuer
Cytek Biosciences, Inc.cik:0001831915
Revision history · 0
No field has changed since this record was first ingested.
